FDA’s annual Generic Drugs Forum is a two-day event designed to facilitate the development and approval of safe, effective, and high-quality generic medicines. Join us April 22-23, 2026.
Similar Posts
Examples of Accepted Emerging Technologies
CDER’s Office of Pharmaceutical Quality created the Emerging Technology Program to promote the adoption of innovative approaches to pharmaceutical product design and manufacturing.A.S.K. Foods, LLC Issues Allergy Alert on Undeclared Soy in Publix Rice & Pigeon Peas
A.S.K. Foods, LLC of Palmyra, PA is recalling select 32 oz. containers of Publix Rice & Pigeon Peas because it contains undeclared soy. People who have an allergy or severe sensitivity to soy run the risk of serious or life-threatening allergic reaction if they consume this product.OMUFA Performance Reports
Over-the-Counter Monograph Drug User Fee annual performance reports to CongressAlert: NOxBOX Ltd. Issues Correction for NOxBOXi Nitric Oxide Delivery System Due to Risk for Nitric Oxide Dosing Fluctuations
There may be nitric oxide dosing fluctuations and therapy interruption when NOxBOXi Nitric Oxide Delivery System is used with certain ventilators.FDA Approves Prescription Nasal Spray to Reverse Opioid Overdose
The U.S. Food and Drug Administration approved Opvee, the first nalmefene hydrochloride nasal spray for the emergency treatment of known or suspected opioid overdose in adults and pediatric patients 12 years of age and olderCDER Center for Clinical Trial Innovation (C3TI)
Enable and amplify existing and future CDER clinical trial innovation through enhanced communication and collaboration